Oritain hits half a billion, but faces Companies Office scrutiny

Oritain hits half a billion, but faces Companies Office scrutiny
Grant Cochrane and director John Key discuss counterfeiting issues. (Image: Oritain)
Brent Melville
Dunedin company Oritain, which specialises in origin tracing and is valued at $558 million, may have to disclose its earnings.Last week, the biotech firm completed a US$57m (NZ$90m) raise, in a series C round led by London venture capital firm Highland Europe, which valued it at just over half a billion dollars.But while its foundation is about traceability, the firm's earnings remain opaque. It doesn’t report its financials in NZ, despite "officially" being overseas owned from December 2021. Under the Companies Ac...

More Finance

FMA gets eligible investor certification clarity
Finance

FMA gets eligible investor certification clarity

High Court Justice Sally Fitzgerald released a 45-page judgment on Thursday.

Sharesies’ app affected by more than hour-long outage
Finance

Sharesies’ app affected by more than hour-long outage

Sharesies portfolio app was down for more than an hour, frustrating US-focused investors.

Nothing to see here – Aussie regulator slams ANZ
Finance

Stock & Trade: Nothing to see here – Aussie regulator slams ANZ

FMA confirms eight complaints over NZ bond trading, but no action was taken.

Life insurance market shrinks
Finance Risky Business

Life insurance market shrinks

Foreign firms dominate as affordability, tax and access barriers stymie growth.

Michael Neilson 18 Sep 2025